A Randomized Phase II Study of Stereotactic Ablative Body Radiotherapy for Metastases to the Lung (TROG 13.01 SAFRON II)
Conditions
- Cancer
- Metastases to the Lung
Interventions
- RADIATION: Multi-fraction SABR
- RADIATION: Single Fraction SABR
Sponsor
Trans Tasman Radiation Oncology Group
Collaborators